| Full Name | David Parsons |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 1700 N Wheeling St, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053776237 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0004308 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Parsons, 6292 S Ash Cir W, Centennial, CO 80121-3136 Ph: () - | David Parsons, 1700 N Wheeling St, Aurora, CO 80045 Ph: (303) 399-8020 |
News Archive
Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.
Emerging Healthcare Solutions, Inc. is negotiating a potential option agreement with biotech firm Regenetech, Inc.
It is a common belief that drugs given the okay by the Food and Drug Administration (FDA) are safer and more effective than they have to be to win approval, according to a new study. Especially in the first few years after a drug becomes available, researchers note, there are still questions about how well it will work and whether it will have any serious side effects warn experts. For example FDA-approved painkiller Vioxx was pulled off the market in 2004 after longer-term evidence showed that it may increase the risk of heart attack and stroke.
The body's natural inflammatory response is an essential reaction to injury and infection. When acute inflammation escalates out of control, such as in sepsis, it causes nearly 10% of deaths in the U.S. and more than $17 billion in healthcare costs each year. A group of researchers have developed a groundbreaking biohybrid device that can control acute inflammation to prevent sepsis and other related life-threatening complications, as described in an article in the inaugural issue of Disruptive Science and Technology.
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced the availability of the first clinical test panel for aiding the diagnosis of suspected dementia due to treatable forms of cognitive impairment. The test panel is believed to be the first commercial service from a clinical laboratory to combine several guideline-recommended tests for identifying secondary, treatable causes of dementia as a single blood test and report.
› Verified 8 days ago
Ms. Carol Yvonne Wall, O.T.R., C.E.A.S Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3451 S Chambers Rd, Aurora, CO 80014 Phone: 303-680-6121 Fax: 303-680-8627 | |
Hatti Owens, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15751 E 1st Ave, Aurora, CO 80011 Phone: 303-340-0510 | |
Mrs. Sanja June Batz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-7447 | |
Lilly O'toole, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7795 S Blackstone Pkwy, Aurora, CO 80016 Phone: 720-886-1400 | |
Susanna Muth, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 24300 E Progress Dr, Aurora, CO 80016 Phone: 720-886-4000 | |
Alexis Reinert, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5954 S Quatar Ct, Aurora, CO 80015 Phone: 303-250-4291 Fax: 720-306-2352 | |
Alyssa Fasoli, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15701 E 1st Ave Ste 109, Aurora, CO 80011 Phone: 303-367-3060 |